Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Flamand

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Stem Cell Reviews and Reports|September 28, 2024
Targeting Cytokines: Evaluating the Potential of Mesenchymal Stem Cell Derived Extracellular Vesicles in the Management of COVID-19Iago Carvalho Schultz, Ana Claudia Dos Santos Pereira Andrade, Isabelle Dubuc, et al.
Blood Advances|April 20, 2022
Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cellsFlorian Puhm, Isabelle Allaeys, Emile Lacasse, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 7, 2025
PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from ImidazoquinolinesMarilène Bolduc, Philippe Saint-Louis, Damien Carignan, et al.
Frontiers in Microbiology|July 12, 2019
Chromatin Profiles of Chromosomally Integrated Human Herpesvirus-6AAnthony J Saviola, Cosima Zimmermann, Michael P Mariani, et al.
Vaccines|April 27, 2026
Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 VariantsLéa-J Blanchette, Marilène Bolduc, Tekeleselassie Woldemariam, et al.
Immunity & Ageing : I & A|March 13, 2025
Delayed viral clearance and altered inflammatory responses affect severity of SARS-CoV-2 infection in aged miceÉmile Lacasse, Isabelle Dubuc, Leslie Gudimard, et al.
RMD Open|November 29, 2023
COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary seriesInes Colmegna, Valeria Valerio, Nathalie Amiable, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 25, 2021
High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patientsAnne-Sophie Archambault, Younes Zaid, Volatiana Rakotoarivelo, et al.
Elife|September 21, 2021
Variation in human herpesvirus 6B telomeric integration, excision, and transmission between tissues and individualsMichael L Wood, Colin D Veal, Rita Neumann, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2025
Deficiency in platelet 12-lipoxygenase exacerbates inflammation and disease severity during SARS-CoV-2 infectionAna Claudia Dos S P Andrade, Emile Lacasse, Isabelle Dubuc, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Stem Cell Reviews and Reports|September 28, 2024
Targeting Cytokines: Evaluating the Potential of Mesenchymal Stem Cell Derived Extracellular Vesicles in the Management of COVID-19Iago Carvalho Schultz, Ana Claudia Dos Santos Pereira Andrade, Isabelle Dubuc, et al.
Blood Advances|April 20, 2022
Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cellsFlorian Puhm, Isabelle Allaeys, Emile Lacasse, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 7, 2025
PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from ImidazoquinolinesMarilène Bolduc, Philippe Saint-Louis, Damien Carignan, et al.
Frontiers in Microbiology|July 12, 2019
Chromatin Profiles of Chromosomally Integrated Human Herpesvirus-6AAnthony J Saviola, Cosima Zimmermann, Michael P Mariani, et al.
Vaccines|April 27, 2026
Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 VariantsLéa-J Blanchette, Marilène Bolduc, Tekeleselassie Woldemariam, et al.
Immunity & Ageing : I & A|March 13, 2025
Delayed viral clearance and altered inflammatory responses affect severity of SARS-CoV-2 infection in aged miceÉmile Lacasse, Isabelle Dubuc, Leslie Gudimard, et al.
RMD Open|November 29, 2023
COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary seriesInes Colmegna, Valeria Valerio, Nathalie Amiable, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 25, 2021
High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patientsAnne-Sophie Archambault, Younes Zaid, Volatiana Rakotoarivelo, et al.
Elife|September 21, 2021
Variation in human herpesvirus 6B telomeric integration, excision, and transmission between tissues and individualsMichael L Wood, Colin D Veal, Rita Neumann, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2025
Deficiency in platelet 12-lipoxygenase exacerbates inflammation and disease severity during SARS-CoV-2 infectionAna Claudia Dos S P Andrade, Emile Lacasse, Isabelle Dubuc, et al.
Pageof 11